UnitedHealthcare

Luigi Mangione pleaded guilty to federal stalking charges related to the death of Brian Thompson in connection with a shooting outside a Midtown hotel on December 4, 2024. His plea has led to questions regarding the separate Manhattan murder case because experts suggest New York’s double-jeopardy law may prevent that trial from proceeding.

Luigi Mangione pleaded guilty in Manhattan federal court to stalking charges after admitting that he targeted and killed UnitedHealthcare CEO Brian Thompson during a 2024 visit. Following his plea, his lawyers filed paperwork seeking to dismiss the parallel state murder case on double jeopardy grounds. Prosecutors plan to seek a life sentence, citing evidence including video footage, DNA, fingerprints, and a recovered pistol.

Luigi Mangione entered a guilty plea to federal stalking-to-kill charges. This development has raised questions regarding how it will affect his separate state murder case. Furthermore, his lawyers are seeking ways to prevent him from spending the rest of his life in prison.

Luigi Mangione pleaded guilty in Manhattan federal court to two stalking charges, admitting he targeted and killed UnitedHealthcare CEO Brian Thompson in 2024. Immediately after his plea, his lawyers filed paperwork attempting to dismiss his parallel state murder case on double jeopardy grounds. Prosecutors are seeking life sentences for Mangione.

Luigi Mangione pleaded guilty to federal stalking-to-kill charges after admitting he targeted and killed UnitedHealthcare CEO Brian Thompson in 2024 in Manhattan. Immediately following the plea, his lawyers filed paperwork claiming double jeopardy regarding a parallel state murder case scheduled for September 8th. The defense team's current strategy is focused on minimizing consequences by appealing to federal judge Margaret Garnett regarding potential life sentences.

Luigi Mangione pleaded guilty to the shooting death of UnitedHealthcare CEO Brian Thompson after admitting he stalked and shot him in 2024 outside a Hilton hotel in Manhattan. The 28-year-old faces potential life in prison and is also dealing with state murder charges for Thompson’s death in New York.

Luigi Mangione is expected to plead guilty in his federal case, which reportedly involves charges of stalking and killing UnitedHealthcare CEO Brian Thompson during an incident in 2024. This federal case will affect a separate state case.

Photos detail the legal case against Luigi Mangione, which involves his suspected killing of Brian Thompson. The legal proceedings cover details from the event in New York City involving UnitedHealthcare's CEO to current developments in the courtroom.

Luigi Mangione's federal hearing concerning the killing of UnitedHealthcare CEO Brian Thompson has raised speculation that he may plead guilty in these proceedings. Separately, Mangione also faces a New York state trial involving charges of murder and weapons, alongside two stalking counts in the federal case. Both criminal cases could potentially result in a life prison sentence.

Luigi Mangione is expected to plead guilty on Friday during a federal case related to a killing. The incident occurred on a Manhattan sidewalk and involved the former UnitedHealthcare CEO.

Luigi Mangione is scheduled for a federal court hearing where he is expected to plead guilty regarding the 2024 killing of UnitedHealthcare CEO Brian Thompson. Mangione faced charges related to ambushing Thompson outside a New York City hotel on Dec. 4, 2024. The cases involve him stalking Thompson, with both federal and state proceedings potentially leading to life imprisonment.

Luigi Mangione is scheduled to appear in federal court for a hearing where he is expected to plead guilty regarding the 2024 killing of UnitedHealthcare CEO Brian Thompson. Mangione was charged with ambushing Thompson outside a New York City hotel on December 4, 2024, and faces separate state murder charges. The case involves complex legal issues regarding potential double jeopardy across federal and state proceedings.

Luigi Mangione could plead guilty to federal criminal charges as soon as Friday. These charges are related to the fatal shooting of UnitedHealthcare CEO Brian Thompson.

Luigi Mangione is scheduled to appear in Manhattan state court regarding the killing of UnitedHealthcare CEO Brian Thompson. Prosecutors allege that Mangione gunned down Thompson outside a Midtown Manhattan hotel on December 4, 2024. This appearance occurs less than a month before his trial starts on September 8.

The highly anticipated murder trial of Luigi Mangione, accused of killing UnitedHealthcare executive Brian Thompson, is facing extra scrutiny and potential disruptions. Concerns have arisen regarding limits on reporters' press access, compounded by global interest and social media influencers gathering at major US criminal cases for clicks and money.

Luigi Mangione's attorneys argue for livestreaming his murder trial to pressure jurors through influencer content, according to a former prosecutor. They claim media access rules are unconstitutional and that increased public attention could lead to jury nullification or acquittal.

Luigi Mangione is seeking to broadcast his trial live. He is facing state charges in the killing of UnitedHealthcare CEO Brian Thompson.

Lawyers for Luigi Mangione argue that media access rules for his state murder trial, which limit coverage to 68 journalists, violate his constitutional right to a public trial. The defense claims the guidelines were created without their consultation and seeks a public hearing and transparency in the selection process.

A local 646 number has been calling the user and their family for over a week, using an unintelligible company name and a case number to demand immediate contact with a UnitedHealthcare number, which the user does not use. The calls shifted to family members after being blocked, with vague voicemails using the user's name to pressure them into calling back.

Manhattan prosecutors warn they may oppose a federal plea deal for Luigi Mangione if it could disrupt his upcoming New York murder trial for the killing of UnitedHealthcare CEO Brian Thompson. A federal judge delayed Mangione's trial to January 2027 to prioritize the state case, and prosecutors emphasized the need to ensure a fair outcome in the state prosecution.

The Trump administration's 2025 pledge to reduce prior authorization barriers in healthcare has faced criticism as insurers delay full implementation, while patients and advocates report little improvement. AHIP claims 6.5 million prior authorizations were eliminated, but critics call the pledge 'performative' and lacking enforcement. A House committee recently advanced a bill to mandate transparency in Medicare Advantage prior authorization processes.

Secretary of State Marco Rubio announced plans to designate more far-left groups as terrorist organizations, citing the assassinations of Charlie Kirk and UnitedHealthcare CEO Brian Thompson, as well as an attempted assassination on President Trump, as examples of a 'distinctive and unique evil' linked to political extremism.

Trump administration officials and Ohio Republicans highlighted investigations into individual Medicaid fraud cases involving $100 million in alleged scams but did not address corporations with large Medicaid contracts, including UnitedHealthcare and CVS Health, which have faced lawsuits and accusations of up-charging by $250 million annually. Acting U.S. Attorney General Todd Blanche emphasized targeting individuals like two Ohio state employees accused of billing $30 million for undelivered services, while corporations with vertically integrated operations remained unmentioned.

Affordable Care Act insurers are proposing a median 14% premium increase for 2027 due to rising medical costs and policy changes, with enrollment declining by 3 million since February 2023. The expiration of enhanced subsidies under former President Trump and increased demand for costly treatments like GLP-1 weight loss drugs are cited as key factors.

Luigi Mangione's federal trial for the killing of UnitedHealthcare CEO Brian Thompson has been delayed until January to allow his lawyers to focus on his state murder trial starting in September. Mangione arrived late to a court hearing due to an elevator malfunction, marking the second recent delay in his court appearances.

Luigi Mangione’s federal trial was postponed to January to avoid overlapping with his state court trial starting in September. The judge cited scheduling conflicts and challenges in conducting jury selection amid media attention and dual proceedings. Mangione faces murder and weapons charges in state court and stalking in federal court for the December 2024 killing of UnitedHealthcare CEO Brian Thompson.

Luigi Mangione’s federal trial in the killing of UnitedHealthcare CEO Brian Thompson has been postponed until January by a judge.

Luigi Mangione’s federal trial for the killing of UnitedHealthcare CEO Brian Thompson has been postponed to January to allow his lawyers to focus on his state murder trial starting in September. The federal trial’s jury selection will begin on January 5, with opening statements on January 25, as Judge Margaret Garnett cited the impossibility of conducting jury selection while Mangione’s team handles the state case.

Luigi Mangione’s federal trial for the killing of UnitedHealthcare CEO Brian Thompson has been postponed to January by U.S. District Judge Margaret Garnett to allow his lawyers to focus on his state murder trial.

A federal judge in Lower Manhattan has set the trial date for Luigi Mangione, who is accused of fatally shooting UnitedHealthcare CEO Brian Thompson. The trial is scheduled for January 2027.

Luigi Mangione's federal trial for the killing of UnitedHealthcare CEO Brian Thompson has been postponed to January. Mangione, 28, pleaded not guilty to federal stalking charges during a hearing in New York City on February 21, 2025.

Luigi Mangione, 28, is scheduled to appear in federal court for a pretrial hearing and faces state and federal charges related to the December 2024 fatal shooting of UnitedHealthcare CEO Brian Thompson outside a Midtown Manhattan hotel. Mangione has pleaded not guilty to the charges.

Luigi Mangione, 28, is set to appear in federal court for a pretrial hearing and has pleaded not guilty to state and federal charges related to the December 2024 shooting of UnitedHealthcare CEO Brian Thompson outside a Midtown Manhattan hotel.

Luigi Mangione, 28, has pleaded not guilty to state and federal charges related to the December 2024 fatal shooting of UnitedHealthcare CEO Brian Thompson outside a Midtown Manhattan hotel.

Luigi Mangione, 28, has pleaded not guilty to both state and federal charges stemming from the December 2024 fatal shooting of UnitedHealthcare CEO Brian Thompson outside a Midtown Manhattan hotel.

Luigi Mangione's pretrial hearing for federal charges related to the shooting death of UnitedHealthcare CEO Brian Thompson is scheduled for Monday at Manhattan Federal Court. Mangione pleaded not guilty to state and federal charges in the case.

A deadlocked jury in the Palisades Fire case has raised concerns about ideological influences in jury decisions, with fears that similar issues could affect Luigi Mangione's trial. Jonathan Rinderknecht, accused of causing the fire, received a mistrial after jurors split 10-2, and a retrial is planned. Former prosecutor Neama Rahmani warns that public sympathy for Mangione, accused of killing UnitedHealthcare CEO Brian Thompson, could lead to jury nullification.

Luigi Mangione's attorneys claim federal prosecutors violated his rights. Mangione faces state and federal charges for UnitedHealthcare CEO Brian Thompson's murder in December 2024 and has pleaded not guilty in both cases.

Luigi Mangione's defense team initially raised an 'extreme emotional disturbance' defense for his murder trial but later withdrew it. The defense claimed the legal strategy could reduce murder charges to manslaughter under New York law, though it requires the defendant to prove emotional distress triggered the killing.

Cadence, a digital health company, raised $100 million in funding led by Spark Capital, valuing the company at $1.23 billion. The investment aims to expand Cadence's chronic disease management programs and automate clinician work with AI, despite scrutiny over its billing model from the federal health department's watchdog and insurers like UnitedHealthcare.